Tata Elxsi and GSMA Announce Joint Focus to Accelerate Operator Network Monetization and Enterprise API Adoption

Tata Elxsi, a global leader in design and technology services, and global mobile industry association, the GSMA have signed a Memorandum of Understanding (MoU) under the GSMA Fusion initiative to help accelerate enterprise API adoption. The collaboration also includes a global Statement of Requirements which aims to help mobile operators unlock new revenue streams by […]

JIN-ASAKUSA Debuts New Course: Sushi x Samurai x Entertainment Experience

Prex Co., Ltd. (Headquarters: Osaka), which operates the highly-rated JIN-ASAKUSA restaurant, has announced the launch of a new course and a limited-time discount. JIN-ASAKUSA, an immersive entertainment restaurant in Tokyo, boasts an exceptional 4.9 Google Review score and is renowned for its unique concept fusing traditional Japanese “Sushi,” the historical element of the “Samurai,” and

A NEW DAWN OF HOLISTIC WELLNESS AT THE RITZ-CARLTON SPA SINGAPORE: REDEFINING LUXURY WITH THE FUTURE OF SKINCARE

The Ritz-Carlton Spa introduces Southeast Asia's first exclusive partnership with EPICUTIS®, pharmaceutical-grade, science-backedskincare The Ritz-Carlton, Millenia Singapore is pleased to announce the Southeast Asia debut of innovative, science-driven skincare brand EPICUTIS®, developed by biotech innovator Signum Biosciences. In this exclusive partnership, The Ritz-Carlton Spa Singapore has been designated as the brand's flagship property in the

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China

Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) — First healthy volunteer dosed with BV100 in China in mandatory Phase 1 trial Inclusion of Chinese clinical sites by H2 2026, into single global Phase 3 registration trial as planned BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing

ArcelorMittal reports third quarter 2025

(LuxSE:MT),(Euronext Amsterdam:MT),(Paris:MT),(Madrid:MTS),(Bolsa de Barcelona:MTS),(Bolsa de Valencia:MTS),(Bolsa de Valores de Bilbao:MTS),(SWX:ARC15),(NYSE:MT), Luxembourg, November 6, 2025 – ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the “Group”) (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company, today announced results1 for the three-month and nine-month periods ended September 30, 2025.

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

(Euronext Amsterdam:PHARM),(NasdaqGM:PHARM),(Euronext Amsterdam:PHARM), Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024 RUCONEST(R) third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting sustained growth in patients and prescribers Joenja(R) (leniolisib) third quarter revenue increased by 35% to US$15.1 million, compared to third

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow GlobeNewswire November 06, 2025 Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024 RUCONEST(R) third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting sustained growth

ArcelorMittal reports third quarter 2025

ArcelorMittal reports third quarter 2025 GlobeNewswire November 06, 2025 Luxembourg, November 6, 2025 – ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the “Group”) (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company, today announced results1 for the three-month and nine-month periods ended September 30, 2025. 3Q

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China GlobeNewswire November 06, 2025 Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) — First healthy volunteer dosed with BV100 in China in mandatory Phase 1 trial Inclusion of Chinese clinical sites by H2 2026,

Older Borrowers Delaying Major Life Decisions Due to Student Debt, RadCred Study Finds

Glendale, CA, Nov. 06, 2025 (GLOBE NEWSWIRE) — RadCred, an AI-powered loan platform, today released findings from its latest debt survey revealing that 64% of borrowers over 40 say outstanding student loans are delaying major life decisions, including home purchases, retirement planning, and starting families. This comes as federal student loan collections resumed in May

Scroll to Top